Evidence map›Paper›PMID 34222864›Full record

ReviewBrain communications2021

Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force.

Irene Beatrix Meier, Camila Vieira Ligo Teixeira, Ioannis Tarnanas, Fareed Mirza, Lawrence Rajendran

Open access · goldAbstract readReview
In one paragraph

Review in Brain communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Association between COVID-19 and outstanding academic performance at a Spanish university.Archives of public health = Archives belges de sante publique · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Irene Beatrix MeierChione GmbH, 8122 Binz, Switzerland.ORCID https://orcid.org/0000-0003-0942-9797
Camila Vieira Ligo TeixeiraBrazilian Institute of Neuroscience and Neurotechnology, 3448433 São Paulo, Brazil.
Ioannis TarnanasAltoida, Inc, Houston, 77027 TX, USA.
Fareed MirzaCenter for Global and Digital Health (CGDH), W1J 5BF London, UK.
Lawrence RajendranUK Dementia Research Institute, King's College London, WC2R 2LS London, UK.
Brazilian Institute of Neuroscience and Neurotechnology · BRKing's College London · GBNHS Digital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent case studies show that the SARS-CoV-2 infectious disease, COVID-19, is associated with accelerated decline of mental health, in particular, cognition in elderly individuals, but also with neurological and neuropsychiatric illness in young people. Recent studies also show a bidirectional link between COVID-19 and mental health in that people with previous history of psychiatric illness have a higher risk for contracting COVID-19 and that COVID-19 patients display a variety of psychiatric illnesses. Risk factors and the response of the central nervous system to the virus show large overlaps with pathophysiological processes associated with Alzheimer's disease, delirium, post-operative cognitive dysfunction and acute disseminated encephalomyelitis, all characterized by cognitive impairment. These similarities lead to the hypothesis that the neurological symptoms could arise from neuroinflammation and immune cell dysfunction both in the periphery as well as in the central nervous system and the assumption that long-term consequences of COVID-19 may lead to cognitive impairment in the well-being of the patient and thus in today's workforce, resulting in large loss of productivity. Therefore, particular attention should be paid to neurological protection during treatment and recovery of COVID-19, while cognitive consequences may require monitoring.

Indexed as

Alzheimer’s diseasecognitive declineCOVID-19post-operative cognitive dysfunctionproduction loss

Identifiers

PMID34222864
PMCPMC7929222
OpenAlexW3127026805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.